Dapagliflozin reduces death from heart failure

Dapagliflozin reduces death from heart failure

The DAPA-VO2 trial, developed over the last three years, has been promoted by Dr. Julio Núñez, deputy scientific director of Incliva and the Cardiology Service of the Clinical Hospital of Valencia Valencia, Wednesday 20.07.22 A. CASAÑ The Health Research Institute tilt, of the Clinical Hospital of Valencia, has promoted a clinical trial which has made …

Dapagliflozin reduces death from heart failure Read More »